Record DCM Fees, Healthcare ECM Bolster Piper Sandler Q1 Results
Piper Sandler posted strong Q1 results led by record Debt Capital Markets advisory fees and Healthcare equity capital markets performance, while overall advisory fees are expected to dip sequentially. Bank M&A volumes slowed on larger transactions and software deal flow waned as valuations fell and rate volatility complicated hedging.
1. Strong Advisory and Capital Markets Performance
Piper Sandler’s Debt Capital Markets advisory business delivered record fees in Q1, driven by high-demand structured financings. The firm also captured outsized market share in Healthcare equity capital markets, bolstering overall revenue despite broader market headwinds.
2. Moderating M&A Activity
Bank M&A deal closings remained solid on smaller transactions, but announced larger deals slowed versus prior quarters. In Technology M&A, software deal volume declined as valuations dropped and buyers adopted a more cautious stance amid sector uncertainty.
3. Rate Volatility Impact on Hedging
Elevated rate volatility in the forward curve kept the firm’s derivative desk exceptionally busy, yet fluctuating rates posed challenges for counterparties finalizing hedging strategies. Completed hedging transactions rose modestly, but volatility continued to influence client positioning.
4. Q2 Outlook and Advisory Trends
Management expects advisory fees to dip sequentially given choppy macro conditions and pockets of slower sponsor activity. While the market remains open, first-quarter market share gains are unlikely to repeat as deal urgency normalizes.